Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.
about
Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.Advances in immunotherapy for pediatric acute myeloid leukemia.Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
P2860
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@ast
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@en
type
label
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@ast
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@en
prefLabel
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@ast
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@en
P2093
P2860
P50
P356
P1476
Natural Killer Defective Matur ...... s with Acute Myeloid Leukemia.
@en
P2093
Anne-Sophie Chretien
Catherine Lacombe
Christine Arnoulet
Claire Galseran
Clemence Demerle
Emilie Gregori
Emmanuel Gautherot
Florence Orlanducci
Gaelle Bouvier Borg
Herve Luche
P2860
P356
10.3389/FIMMU.2017.00573
P577
2017-05-29T00:00:00Z